Cancer Epidem Biomar:研究确定诱发高血压的又一大诱因

2017-11-22 佚名 medicalxpress

发表于《癌症流行病学》杂志上的文章指出,儿童癌症的幸存者患高血压的风险是普通人群的两倍多.

发表于《癌症流行病学》杂志上的文章指出,儿童癌症的幸存者患高血压的风险是普通人群的两倍多.

不断改善的小儿癌症治疗方法大大提高了患者的生存率,据统计,约有83%的儿童五年生存率达到5年,许多都成为了长期的幸存者。如今,据估计,美国有420000成年人士儿童癌症幸存者。

然而,他们中的很多人都在忍受着长期的副作用。“高血压就是其中之一,我们都知道,高血压会增加心脏问题的风险。研究表明,儿童癌症幸存者是高血压的高危人群,可能是由于抗癌疗法的药物,如蒽环霉素或胸部辐射。”

在此次研究中,研究人员研究了3016名成年人,他们都是儿童癌症的幸存者,并且在接受长期健康监测,这些参与者的收缩压都在140及以上。研究表明,高血压的患病率在儿童癌症幸存者中是其他人的2.6倍。另外,高血压的患病率会随着时间的推移而增加,30岁时,13%的幸存者患有高血压,40岁时,37%患者有高血压,到50岁时,超过70%的幸存者有高血压。

研究人员表示:“好消息是,与癌症治疗相比,高血压是一种可改变的危险因素,但我们强调有效的干预措施,以防止高血压带来的健康隐患,血压监测和管理的重要性值得提到日程中来。”

原始出处:

Todd M. Gibson, Zhenghong Li, Daniel M. Green, et.al. Blood Pressure Status in Adult Survivors of Childhood Cancer: A Report from the St. Jude Lifetime Cohort Study. Cancer Epidemiology, Biomarkers & Prevention

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1917794, encodeId=3009191e7943e, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Wed Apr 11 09:57:00 CST 2018, time=2018-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=265397, encodeId=434426539e8f, content=非常好的文章.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Wed Nov 29 19:53:27 CST 2017, time=2017-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263628, encodeId=5aed26362898, content=非常好的文章.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Thu Nov 23 13:52:17 CST 2017, time=2017-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263418, encodeId=228526341857, content=谢谢分享学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM7GibvIBibibnnnvpajk2stlDF5oichYahI6Bia8uxeTBFoPbdoHWebyXf9eal9FNgUF2lNcrwoZicM3BvQ/0, createdBy=a3742066385, createdName=戒馋,懒,贪, createdTime=Wed Nov 22 21:18:17 CST 2017, time=2017-11-22, status=1, ipAttribution=)]
    2018-04-11 sunylz
  2. [GetPortalCommentsPageByObjectIdResponse(id=1917794, encodeId=3009191e7943e, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Wed Apr 11 09:57:00 CST 2018, time=2018-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=265397, encodeId=434426539e8f, content=非常好的文章.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Wed Nov 29 19:53:27 CST 2017, time=2017-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263628, encodeId=5aed26362898, content=非常好的文章.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Thu Nov 23 13:52:17 CST 2017, time=2017-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263418, encodeId=228526341857, content=谢谢分享学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM7GibvIBibibnnnvpajk2stlDF5oichYahI6Bia8uxeTBFoPbdoHWebyXf9eal9FNgUF2lNcrwoZicM3BvQ/0, createdBy=a3742066385, createdName=戒馋,懒,贪, createdTime=Wed Nov 22 21:18:17 CST 2017, time=2017-11-22, status=1, ipAttribution=)]
    2017-11-29 天涯183

    非常好的文章.学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1917794, encodeId=3009191e7943e, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Wed Apr 11 09:57:00 CST 2018, time=2018-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=265397, encodeId=434426539e8f, content=非常好的文章.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Wed Nov 29 19:53:27 CST 2017, time=2017-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263628, encodeId=5aed26362898, content=非常好的文章.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Thu Nov 23 13:52:17 CST 2017, time=2017-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263418, encodeId=228526341857, content=谢谢分享学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM7GibvIBibibnnnvpajk2stlDF5oichYahI6Bia8uxeTBFoPbdoHWebyXf9eal9FNgUF2lNcrwoZicM3BvQ/0, createdBy=a3742066385, createdName=戒馋,懒,贪, createdTime=Wed Nov 22 21:18:17 CST 2017, time=2017-11-22, status=1, ipAttribution=)]
    2017-11-23 天涯183

    非常好的文章.学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1917794, encodeId=3009191e7943e, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Wed Apr 11 09:57:00 CST 2018, time=2018-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=265397, encodeId=434426539e8f, content=非常好的文章.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Wed Nov 29 19:53:27 CST 2017, time=2017-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263628, encodeId=5aed26362898, content=非常好的文章.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Thu Nov 23 13:52:17 CST 2017, time=2017-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263418, encodeId=228526341857, content=谢谢分享学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM7GibvIBibibnnnvpajk2stlDF5oichYahI6Bia8uxeTBFoPbdoHWebyXf9eal9FNgUF2lNcrwoZicM3BvQ/0, createdBy=a3742066385, createdName=戒馋,懒,贪, createdTime=Wed Nov 22 21:18:17 CST 2017, time=2017-11-22, status=1, ipAttribution=)]
    2017-11-22 戒馋,懒,贪

    谢谢分享学习了

    0

相关资讯

SCI REP:哮喘与高血压之间的相关性存在性别特异性!

该研究的结果表明,哮喘病理生理学与年轻人高血压之间相关性的差异可能与性别有关。

JAHA:心电图提示左室肥大的高血压患者预后明显更差

高血压患者伴有左室肥大(LVH)心电图表现的心源性死亡率和发病率均更高,但是单一的心电图诊断标准可能会低估了心血管风险。本研究纳入了9193名随机分配至氯沙坦或阿替洛尔治疗组的高血压患者,通过康奈尔法和/或Sokolow‐Lyon法对患者左室肥大心电图进行诊断,在4.8±0.9年的随访时间里,对患者的卒中、心梗、心源性死亡、复合结局和全因死亡率与患者心电图的关系进行评估。研究开始时,将患者根据每个

心血管经典病例推荐——高血压病

高血压是最常见的常见的慢性疾病,也是心脑血管病最主要的危险因素。目前全球约有10亿高血压患者。目前高血压采用的是2005年中国高血压治疗指南建议的标准,一般以收缩压(mmHg)≥140、舒张压≥90(mmHg)作为诊断高血压的标准。今年11月15日美国将高血压的标准下调为130/80(mmHg)。 病史: 患者为一67岁老年女性,平素体健,有高血压家族史,其他无殊。

JAHA:血压>150/95 mm Hg的患者推荐使用联合药物治疗

根据高血压患者不同情况的分层,不同指南对初始联合治疗或初始单药治疗的推荐各不相同,本研究的目的旨在比较评估这些疗法的有效性和可接受性。本次随机双盲对照临床研究纳入了605名18-79岁尚未接受治疗的收缩压≥150mmHg或舒张压≥95mmHg的高血压患者,随访时间为1年。在前期(0-16周),所有患者被随机分至初始单药治疗组(氯沙坦50 - 100毫克或氢氯噻嗪-12.5-25毫克)或初始联合治疗

Hepatology:研究发现一种抗癌疗法竟也是治疗高血压的神奇方法!

乔治敦大学医学中心的调查人员说,旨在阻止癌症发展的药物可能为控制高血压(高血压)提供了新的途径。这一发现可以为高血压治疗提供一个真正的进展,因为尽管现在有一些高血压药物可以使用,但它们的作用机制并不适用于所有患者。

JAMA:成人高血压的预防、检测、评估和管理指南2017

2017年11月13日,美国心脏病学会(ACC)和美国心脏协会(AHA)公布了新的成人高血压的预防、检测、评估和管理指南并在线发表于国际知名的医学杂志JAMA上